Daniel, Jacinta .

HRN: 02-18-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2025
COTRIMOXAZOLE 960MG (TAB)
11/15/2025
11/22/2025
PO
960mg
Q6h
S. Kloosi Infection
Waiting Final Action 

Indication:  Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: